GlassScriptPhysician profile
Maneesh C Sharma
NPI 1740211630
$1,377.22
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2020: $282 · 2021: $294 · 2022: $335 · 2023: $94.32 · 2024: $4.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $98.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $98.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $577.27 | 2019-2022 | |
| Horizon Therapeutics Plc | $272.00 | 2022-2023 | Krystexxa |
| Stimwave Technologies Incorporated | $141.29 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $111.33 | 2019 | |
| Medtronic USA, INC. | $77.11 | 2019 | |
| Pfizer INC. | $41.61 | 2019 | |
| Collegium Pharmaceutical, INC. | $38.44 | 2019 | |
| Mdd US Operations, LLC | $28.10 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.67 | 2019 | |
| Virtus Pharmaceuticals LLC | $17.14 | 2021 | |
| Fidia Pharma USA INC. | $15.08 | 2022 | |
| Supernus Pharmaceuticals, INC. | $13.51 | 2019 | |
| Acacia Pharma INC | $13.34 | 2021 | |
| Saluda Medical Americas, INC. | $4.33 | 2024 | Evoke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maneesh Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.